Replies to post #676386 on NorthWest Biotherapeutics Inc (NWBO)

[User-840664]

"Appraisal" of... not approval of. ;)

[StonkMaster]

I like it.

[flipper44]

Now ask yourself, why did they say they will continue to monitor timelines.

05 March 2024 A meeting was held between NICE and the company in early-February regarding next steps for the appraisal of DCVax-L for treating glioblastoma, and more information WILL BE AVAILABLE in due course. NICE will continue liaising with the company and “monitoring timelines”. — NICE

Consider that there are two timelines.

We aim to publish final guidance (regarding appraisal timeline) for all new technologies within 90 days of receiving marketing authorisation (regarding MAA timeline) — NICE

Note: Within 90 days can mean well within, as DocLogic points out, NICE is trying to have appraisals happen nearly simultaneously after marketing approvals.

In other words, they are monitoring the appraisal timeline in juxtaposition to the approval timeline.

Got it?